Standardised outcomes in nephrology - Haemodialysis (SONG-HD): Study protocol for establishing a core outcome set in haemodialysis

Trials

Volumn 16, Issue 1, 2015, Pages

  Tong, Allison ^a,b   Manns, Braden ^c   Hemmelgarn, Brenda ^c   Wheeler, David C ^d   Tugwell, Peter ^e   Winkelmayer, Wolfgang C ^f   van Biesen, Wim ^g   Crowe, Sally ^h   Kerr, Peter G ⁱ   Polkinghorne, Kevan R ^i,j   Howard, Kirsten ^k   Pollock, Carol ^l   Hawley, Carmel M ^m,n,o   Johnson, David W ^m,n,o   McDonald, Stephen P ^p,q   Gallagher, Martin P ^o,r   Urquhart Secord, Rachel ^a,b   Craig, Jonathan C ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF OTTAWA   (Canada)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g GHENT UNIVERSITY HOSPITAL   (Belgium)

^h PIC Europe   (United Kingdom)

ⁱ MONASH MEDICAL CENTRE   (Australia)

^j MONASH UNIVERSITY   (Australia)

^k UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^l UNIVERSITY OF SYDNEY   (Australia)

^m UNIVERSITY OF QUEENSLAND   (Australia)

ⁿ TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

^o Metro South and Ipswich Nephrology and Transplant Services ^*  (Australia)

^p ROYAL ADELAIDE HOSPITAL   (Australia)

^q UNIVERSITY OF ADELAIDE   (Australia)

^r UNIVERSITY OF SYDNEY   (Australia)

more..

Author keywords

Chronic kidney disease; Core outcome set; Dialysis; Haemodialysis; Outcomes research; Patient centred outcomes clinical trials

Indexed keywords

ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL STUDY; HEMODIALYSIS; HUMAN; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PUBLIC OPINION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDIZATION; STUDY DESIGN; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; WORKSHOP; CLINICAL TRIAL (TOPIC); CONSENSUS; CONSENSUS DEVELOPMENT; DELPHI STUDY; LITERATURE; METHODOLOGY; NEPHROLOGY; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; STANDARDS;

CLINICAL TRIALS AS TOPIC; CONSENSUS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DELPHI TECHNIQUE; HUMANS; NEPHROLOGY; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; TREATMENT OUTCOME;

EID: 84939531642     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0895-7     Document Type: Article

References (65)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med. 2004;351:1296-305.
2. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Am J Kidney Dis. 2007;72:247-59.
3. Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311:2518-31.
4. Australian Institute of Health and Welfare. Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020. Canberra, Australia: Australian Institute of Health and Welfare; 2014.
5. Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006;333:1047.
6. Klarenbach S, Manns B. Economic evaluation of dialysis therapies. Semin Nephrol. 2009;29:524-32.
7. Pai AB, Cardone KE, Manley HJ, St Peter WL, Shaffer R, Somers M, et al. Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach. Clin J Am Soc Nephrol. 2013;8:1988-99.
8. Australian Institute for Health and Welfare. Health care expenditure on chronic kidney disease 2004-05. Canberra, Australia: Australian Institute for Health and Welfare; 2009.
9. Karopadi AN, Mason G, Rettore E, Ronco C. The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective. Nephrol Dial Transplant. 2014;29:885-92.
10. Neovius M, Jacobson SH, Eriksson JK, Elinder CG, Hylander B. Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study. BMJ Open. 2014;4:e004251.
11. Robinson BM, Zhang J, Morgenstern H, Bradbury BD, Ng LJ, McCullough KP, et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 2014;85:158-65.
12. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302:1782-89.
13. ANZDATA. The 36th Annual Report. Adelaide, Australia: Australian and New Zealand Dialysis and Transplantation Registry; 2013.
14. Wong G, Howard K, Chapman JR, Pollock C, Chadban SC, Salkeld G, et al. How do people with chronic kidney disease value cancer-related quality of life? Nephrology. 2012;17:32-41.
15. Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 2012;9:e1001307.
16. Jones A, Edwards L, Higgins GY, Webster AC, Craig JC. Cochrane Renal Group. About the Cochrane Collaboration (Cochrane Review Groups (CRGS)). onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/sect0-meta.html. Accessed 31 March 2015.
17. Inrig JK, Califf RM, Tasneem A, Vegunta RK, Molina C, Stanifer JW, et al. The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov. Am J Kidney Dis. 2014;63:771-80.
18. Nissenson AR. Improving outcomes for ESRD patients: shifting the quality paradigm. Clin J Am Soc Nephrol. 2014;9:430-34.
19. Boers M, Kirwan JR, Tugwell P, Beaton D, Bingham III CO, Conaghan PG, et al. The OMERACT Handbook. Ottowa, ON, Canada: OMERACT; 2014.
20. Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156-65.
21. Gargon E, Gurung B, Medley N, Altman DG, Blazeby JM, Clarke M, et al. Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One. 2014;9:e99111.
22. Ghandi GY. Patient-important outcomes in registered diabetes trials. JAMA. 2008;299:2543-49.
23. Williamson PR, Altman D, Blazeby JM, Clarke M, Devane D, Gargon E, et al. Developing core outcomes sets for clinical trials: issues to consider. Trials. 2012;13:132.
24. Dwan K, Gamble C, Williamson PR, Kirkham JJ. Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review. PLoS One. 2013;8:e66844.
25. Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ. 2012;344:d7202.
26. Saini P, Loke YK, Gamble C, Altman DG, Williamson PR, Kirkham JJ. Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews. BMJ. 2014;349:g6501.
27. Corner J, Wright D, Hopkinson J, Gunaratnam Y, McDonald JW, Foster C. The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer. 2007;96:875-81.
28. Owens C, Ley A, Aitken P. Do different stakeholder groups share mental health research priorities? A four-arm Delphi study. Health Expect. 2008;11:418-31.
29. Tong A, Crowe S, Chando S, Cass A, Chadban SJ, Chapman JR, et al. Research priorities in chronic kidney disease for Australia: report of a conference. Am J Kidney Dis. Am J Kidney Dis. 2015;66:212-22.
30. Manns B, Hemmelgarn B, Lillie E, Dip SC, Cyr A, Gladish M, et al. Setting research priorities for patients on or nearing dialysis. Clin J Am Soc Nephrol. 2014;9:1813-21.
31. Yudkin JS, Lipska KJ, Montori VM. The idolatory of the surrogate. BMJ. 2011;343:d7995.
32. Svensson S, Menkes DB, Lexchin J. Surrogate outcomes in clinical trials: a cautionary tale. JAMA Intern Med. 2013;173:612-12.
33. Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet. 2007;369:381-88.
34. Clement FM, Klarenbach S, Tonelli M, Johnson JA, Manns BJ. The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Arch Intern Med. 2009;169:1104-12.
35. Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, et al. Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis. 2012;60:102-11.
36. Morton RL, Tong A, Howard K, Snelling P, Webster AC. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ. 2010;340:c112.
37. Morton RL, Tong A, Webster AC, Snelling P, Howard K. Characteristics of dialysis important to patients and family caregivers: a mixed methods approach. Nephrol Dial Transplant. 2011;26:4038-46.
38. Howell M, Tong A, Wong G, Craig JC, Howard K. Important outcomes for kidney transplant recipients: a nominal group and qualitative study. Am J Kidney Dis. 2012;60:186-96.
39. Tong A, Chando S, Crowe S, Manns B, Winkelmayer WC, Hemmelgarn B, et al. Research priority setting in kidney disease. Am J Kidney Dis. 2015;65:674-83.
40. Tong A, Jesudason S, Craig JC, Winkelmayer WC. Perspectives on pregnancy in women with chronic kidney disease: systematic review of qualitative studies. Nephrol Dial Transplant. 2015;30:652-61.
41. Tong A, Lesmana B, Johnson DW, Wong G, Campbell D, Craig JC. The perspectives of adults living with peritoneal dialysis: thematic synthesis of qualitative studies. Am J Kidney Dis. 2013;61:873-88.
42. Tong A, Palmer S, Manns B, Craig JC, Ruospo M, Gargano L, et al. The beliefs and expectations of patients and caregivers about home haemodialysis: an interview study. BMJ Open. 2013;3:e002148.
43. Tong A, Sainsbury P, Carter SM, Hall B, Harris DC, Walker RG, et al. Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrol Dial Transplant. 2008;23:3206-14.
44. Tong A, Winkelmayer WC, Craig JC. Qualitative research in CKD: an overview of methods and applications. Am J Kidney Dis. 2014;64:338-46.
45. Bauman AE, Fardy JH, Harris PG. Getting it right: why bother with patient-centred care? MJA. 2003;179:253-56.
46. Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol. 2014;67:745-53.
47. Kirkham JJ, Boers M, Tugwell P, Clarke M, Williamson PR. Outcome measures in rheumatoid arthritis randomised trials over the last 50 years. Trials. 2013;14:324.
48. Kirkham JJ, Gargon E, Clarke M, Williamson PR. Can a core outcome set improve the quality of systematic reviews?-a survey of the Co-ordinating Editors of Cochrane Review Groups. Trials. 2013;14:21.
49. Waters AM, Tudur Smith C, Young B, Jones TM. The CONSENSUS study: protocol for a mixed methods study to establish which outcomes should be included in a core outcome set for oropharyngeal cancer. Trials. 2014;15:168.
50. Harman NL, Bruce IA, Callery P, Tierney S, Sharif MO, O'Brien K, et al. MOMENT--Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2013;14:70.
51. Schmitt J, Spuls PI, Thomas KS, Simpson E, Furue M, Deckert S, et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol. 2014;134:800-7.
52. Chiarotto A, Terwee CB, Deyo RA, Boers M, Lin CW, Buchbinder R, et al. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set. Trials. 2014;15:511.
53. Prinsen CA, Vohra S, Rose MR, King-Jones S, Ishaque S, Bhaloo Z. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'. Trials. 2014;15:247.
54. Clark M. Standardising outcomes for clinical trials and systematic reviews. Trials. 2007;8:39.
55. Stucki G, Boonen A, Tugwell P, Cieza A, Boers M. The World Health Organisation International Classification of Functioning, Disability and Health: a conceptual model and interface for the OMERACT process. J Rheumatol. 2007;34:600-6.
56. Black N. Consensus development methods. Qualitative research in health care. Malden, MA: Blackwell Publishing; 2006.
57. Jones J, Hunter D. Qualitative research: consensus methods for medical and health services research. BMJ. 1995;311:376-80.
58. Corbin F, Strauss A. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Los Angeles, CA: Sage; 2008.
59. Kuper A, Reeves S, Levinson W. An introduction to reading and appraising qualitative research. Br Med J. 2008;337:a288.
60. Tong A, Sainsbury P, Craig JC. Consolidated criteria for reporting qualitative research (COREQ): a 32 item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:249-57.
61. Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011;8:e1000393.
62. Schunemann H, Brozek J, Oxman AD. GRADE handbook for grading quality of evidence and strength of recommendation. 2009.
63. Louviere JJ, Flynn TN. Using best-worst scaling choice experiments to measure public perceptions and prefernces for healthcare reform in Australia. Patient. 2010;3:275-83.
64. Hensher DA, Rose JM, Greene WH. Applied Choice Analysis: A Primer. Cambridge, UK: Cambridge University Press; 2005.
65. Fiebig D, Keane M, Louviere J, Wasi N. The generalized multinomial logit model: Accounting for scale and coefficient heterogeneity. Mark Sci. 2010;29:393-421.